Hologic Expects Q3 Adj EPS Of $0.98-$1.05 (Est $1.02), Revenue Of $992.5M-$1,007.5M (Est $1.011B)
Portfolio Pulse from Benzinga Newsdesk
Hologic has provided its Q3 earnings and revenue guidance, expecting adjusted EPS to range between $0.98 and $1.05, with revenue projections between $992.5M and $1,007.5M. These figures are slightly below the consensus estimates of $1.02 for EPS and $1.011B for revenue.
May 02, 2024 | 8:26 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Hologic's Q3 guidance indicates a potential shortfall in both earnings and revenue compared to analyst expectations, with adjusted EPS and revenue forecasts slightly below the consensus estimates.
Hologic's guidance for Q3 suggests a potential underperformance against market expectations, which could lead to negative investor sentiment in the short term. The company's forecasted adjusted EPS and revenue are both slightly below the consensus estimates, indicating a cautious outlook that may disappoint investors looking for signs of stronger growth. This cautious guidance is likely to impact the stock price negatively in the short term as the market adjusts to the new projections.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100